Clinical Trials

Viewing: Preparing to Open

Filter by

Trial Stage
  • Trial Stage
  • Closed to Recruitment
  • Completed
  • In Development
  • Open
  • Preparing to Open
Location
  • Location
  • New Zealand
  • NSW
  • QLD
  • SA
  • TAS
  • VIC
  • WA
Disease Type
  • Disease Type
  • Bone Cancers (Ewing Sarcoma/Osteosarcoma)
  • Brain and other Central Nervous System (CNS) Tumours
  • Germ Cell Tumours
  • Hodgkin Lymphoma
  • Kidney (Renal) Tumours
  • Leukaemia
  • Liver tumours
  • Neuroblastoma
  • Non-Hodgkin Lymphoma
  • Other
  • Soft Tissue Sarcomas
Disease Stage
  • Disease Stage
  • Newly diagnosed
  • Other
  • Relapsed/Recurrent

PNOC029: Nivolumab and DAY101 for the...

Brain and other Central Nervous System (CNS) Tumours
Status: Preparing to Open | TAS, VIC, WA

Newly diagnosed, Relapsed/Recurrent
Read more

PNOC029

Brain and other Central Nervous System (CNS) Tumours
Status: Preparing to Open

Nivolumab and DAY101 for the treatment of newly diagnosed or recurrent craniopharyngioma in children and young adults

Newly diagnosed, Relapsed/Recurrent
Read more

All posts loaded.

All posts loaded.

Join our newsletter

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Email info@anzchog.org   |  

Level 6, TRF Building, Hudson Institute, 27-31 Wright St, Clayton VIC 3168

ANZCHOG acknowledges Traditional Owners of Country throughout Australia and recognises the continuing connection to lands, waters and communities. We pay our respect to Aboriginal and Torres Strait Islander cultures, and to Elders both past and present. We acknowledge Māori as tangata whenua of Aotearoa New Zealand and as Treaty partners with the Crown as agreed in Te Tiriti o Waitangi. 

We are committed to creating a safe and welcoming environment that embraces all backgrounds, cultures, sexualities, genders and abilities.